GGrantIndex
Sort

16,300 grants matching fatty liver disease

Gut Flora metabolism of dietary carnitine and cardiovascular disease

$786,871
Stanley L Hazen · Cleveland Clinic Lerner Com-Cwru · R01 · FY2023 · HL

Gut Flora metabolism of dietary carnitine and cardiovascular disease

$786,871
Stanley L Hazen · Cleveland Clinic Lerner Com-Cwru · R01 · FY2022 · HL

Alcohol Metabolism, Functional Consequences and Apoptosis Signaling Mechanism

$786,684
Byoung-Joon Song · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2016 · AA

Post-transcriptional regulation of hepatokines and systemic metabolism

$786,216
Thomas A Vallim · University Of California Los Angeles · R01 · FY2025 · DK

A Novel Plasminogen Receptor Promotes Adipose Function and Metabolic Homeostasis

$786,096
Lindsey A Miles · Scripps Research Institute, The · R01 · FY2019 · HL

Gut Flora metabolism of dietary carnitine and cardiovascular disease

$786,057
Stanley L Hazen · Cleveland Clinic Lerner Com-Cwru · R01 · FY2020 · HL

The role of signaling adaptor protein epsin in atherosclerosis

$785,922
Hong Chen · Boston Children'S Hospital · R01 · FY2023 · HL

Modeling diabetes using an integrated plate system

$785,782
James M Wells · Cincinnati Childrens Hosp Med Ctr · UG3 · FY2019 · DK

Next-generation human liver gene therapy

$785,743
Holger Willenbring · University Of California, San Francisco · DP1 · FY2025 · DK

The role of signaling adaptor protein epsin in atherosclerosis

$785,718
Hong Chen · Boston Children'S Hospital · R01 · FY2022 · HL

Next-generation human liver gene therapy

$785,647
Holger Willenbring · University Of California, San Francisco · DP1 · FY2023 · DK

Next-generation human liver gene therapy

$785,601
Holger Willenbring · University Of California, San Francisco · DP1 · FY2022 · DK

Glutathione, Brain Metabolism and Inflammation in Alzheimer's Disease

$785,596
Rajagopal Viswanath Sekhar · Baylor College Of Medicine · R01 · FY2025 · AG

Next-generation human liver gene therapy

$785,554
Holger Willenbring · University Of California, San Francisco · DP1 · FY2021 · DK

Altered Glucose and Lipid Metabolism in Obesity and CVD

$785,418
Maureen J Charron · Albert Einstein College Of Medicine · R01 · FY2007 · HL

Molecular Biology of the Metastatic Phenotype

$785,037
Patricia Schriver Steeg · Division Of Clinical Sciences - Nci · ZIA · FY2015 · CA

Longitudinal integration of environmental exposures, omics, and childhood NAFLD (LEON) Study

$784,467
Vaia Lida Chatzi · University Of Southern California · U01 · FY2025 · HG

A ketogenic longevity diet for resistance to age-related functional decline and Alzheimer's disease

$783,430
Gino A Cortopassi · University Of California At Davis · R56 · FY2018 · AG

Extracellular vesicle cargo and risk of NAFLD and NASH in Latino youth

$783,329
Johanna K Distefano · Translational Genomics Research Inst · R01 · FY2023 · DK

Genetic Requirements for the survival of Tubercle Bacilli in Nonhuman Primates

$782,989
Deepak Kaushal · Tulane University Of Louisiana · R01 · FY2012 · AI

Novel IL-23 inhibitor for the treatment of alcohol associated liver disease

$782,852
Rohit Loomba · University Of California, San Diego · U01 · FY2020 · AA

Development and validation of a novel 3D human in vitro model of nonalcoholic steatohepatitis to be used for novel therapeutic screening and research on disease mechanism.

$782,018
Alice Chen · Organovo, Inc. · R44 · FY2018 · DK

Hispanic Latino Lipid Consortium

$781,969
Kari E North · Univ Of North Carolina Chapel Hill · R01 · FY2019 · HL

Macrophage Inflammarafts and Mitochondrial Dysfunction in Atherosclerosis

$781,558
Yury Miller · University Of California, San Diego · R01 · FY2025 · HL

Genetically-based neuro-modulation of adipose tissue functions

$781,440
Heike Muenzberg-Gruening · Lsu Pennington Biomedical Research Ctr · OT2 · FY2016 · OD